Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Biosci Biotechnol Biochem ; 66(9): 1955-8, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12400698

ABSTRACT

We investigated the effects of oolong tea on the basic metabolism of plasma lipids in mice under restraint stress. When a lipid emulsion (Intralipid 20%; a lipid emulsion containing 20% soybean oil) was injected intravenously into mice, the restraint stress prolonged the half-life (T 1/2) of elimination for plasma triglyceride (TG) from 28.7 to 55.5 min. The elimination rate per minute was 48.2% in stressed mice with the rate in starved control mice as 100%. Therefore, TG metabolism was disrupted by the stress, and the use of TG as an energy source decreased. We found that the metabolism of lipids significantly response to the restrained stress in the present study. Plasma TG was 515.9 +/- 29.9mg/dl 35min after Intralipid administration in control stressed mice, 478.7 +/- 26.7 mg/dl in the stressed group given caffeine 100 mg/kg of body weight, and 418.3 +/- 18.4 mg/dl in the stressed group given 1,000 mg/kg oolong tea, an improvement by 7.2% and 18.9%, respectively, with the value for the untreated control group. The intake of oolong tea alleviated the stress-induced decrease in the rate of blood lipid metabolism; this effect may have arisen from some non-specific stress-relieving property of the tea or from acceleration of lipid metabolism by properties of polyphenols, etc. in tea. Oolong tea had anti-stress effects on plasma TG metabolism, and the effects did not depend on caffeine.


Subject(s)
Lipid Metabolism , Lipids/blood , Restraint, Physical , Stress, Physiological/blood , Stress, Physiological/metabolism , Tea , Animals , Caffeine/pharmacology , Drinking , Fat Emulsions, Intravenous/administration & dosage , Fat Emulsions, Intravenous/pharmacokinetics , Female , Half-Life , Lipids/administration & dosage , Lipids/pharmacokinetics , Mice , Mice, Inbred ICR , Triglycerides/blood , Triglycerides/metabolism
2.
Biochem Pharmacol ; 64(7): 1187, 2002 Oct 01.
Article in English | MEDLINE | ID: mdl-12234623

ABSTRACT

Intradermal injection of human chymase (EC 3.4.21.39) into the mouse ear elicited an edematous skin reaction in a biphasic manner, with a transient reaction peaking at 1 hr, followed by a delayed response persisting for at least 24hr. The kinetics of this reaction was analogous to the biphasic skin reaction induced by ascaris extract in actively sensitized mice. A similarity between the two dermatitis models was also shown by histological analysis, i.e. accumulation of inflammatory cells was observed exclusively in the later phases of the skin reaction. A chymase inhibitor, SUN-C8077 [3-(3-aminophenylsulfonyl)-7-chloroquinazorine 2,4(1H, 3H)-dione], significantly inhibited both the early- and late-phase responses of the skin reaction induced by ascaris extract. These findings suggest that chymase may play an important role in the allergen-induced biphasic skin reaction. A histamine receptor antagonist, homochlorcyclizine, inhibited the early-phase but not the late-phase of the chymase-induced skin reaction. In addition, human chymase showed chemotactic activity to human polymorphonuclear leukocytes in vitro. Mast cell chymase may participate in the two phases of allergic skin inflammation by two distinct mechanisms, i.e. histamine- and leukocyte-dependent mechanisms, respectively.


Subject(s)
Dermatitis, Atopic/pathology , Hypersensitivity/pathology , Mast Cells/enzymology , Serine Endopeptidases/pharmacology , Animals , Chemotaxis , Chymases , Dermatitis, Atopic/chemically induced , Dermatitis, Atopic/drug therapy , Disease Models, Animal , Edema/chemically induced , Edema/prevention & control , Histamine Antagonists/therapeutic use , Humans , Leukocytes/drug effects , Leukocytes/physiology , Mice , Mice, Inbred BALB C , Recombinant Proteins/pharmacology
3.
Ann N Y Acad Sci ; 957: 325-8, 2002 May.
Article in English | MEDLINE | ID: mdl-12074990

ABSTRACT

We have shown that drinking red wine reduces oxidation of LDL. This reduction in oxidation has been attributed to the polyphenolic compounds in red wine, but the mechanisms of absorption and metabolism of these compounds has been unclear. We therefore investigated the absorption and metabolism of polyphenols using rats to identify their active forms in biological fluids. We also investigated the effect of tartaric acid (TA), a major organic acid in wine, on the absorption of polyphenols. Our results suggested that low molecular weight polyphenols are absorbed in the intestine and metabolized to their glucuronide conjugates, which exhibit antioxidative activity in plasma, and that TA can enhance the bioavailability of wine polyphenols.


Subject(s)
Antioxidants/metabolism , Antioxidants/pharmacokinetics , Flavonoids , Phenols/metabolism , Phenols/pharmacokinetics , Polymers/metabolism , Polymers/pharmacokinetics , Wine , Absorption/drug effects , Animals , Catechin/metabolism , Catechin/pharmacokinetics , Gallic Acid/metabolism , Gallic Acid/pharmacokinetics , Hydroxybenzoates/metabolism , Hydroxybenzoates/pharmacokinetics , Male , Rats , Rats, Wistar , Tartrates/pharmacology
4.
Lab Invest ; 82(6): 789-94, 2002 Jun.
Article in English | MEDLINE | ID: mdl-12065690

ABSTRACT

An epicutaneous application of 2,4-dinitrofluorobenzene (DNFB) to a mouse ear caused a transient skin swelling, and the repetition of the challenge enlarged the contact dermatitis. The repeated challenge with DNFB also induced eosinophil infiltration on the application site. Administration of a chymase inhibitor significantly inhibited the ear swelling as well as eosinophil accumulation. An intradermal injection of human chymase to the mouse ear also elicited transient skin swelling and eosinophil infiltration, both of which were augmented in proportion to the number of injections. Human serum albumin and heat-inactivated chymase failed to induce such skin reactions, suggesting the participation of proteolytic activity of the enzyme. In addition, chymase stimulated eosinophil migration in vitro in a concentration-dependent manner. Taken together, these observations suggest that mast cell chymase may contribute to development of the DNFB-induced dermatitis, probably by promoting eosinophil infiltration. It is therefore possible that chymase plays a role in pathogenesis of chronic dermatitis such as atopic dermatitis.


Subject(s)
Dermatitis, Contact/enzymology , Eosinophilia/enzymology , Eosinophils/enzymology , Serine Endopeptidases/metabolism , Administration, Topical , Allergens/administration & dosage , Allergens/immunology , Allergens/toxicity , Animals , Chymases , Dermatitis, Contact/drug therapy , Dermatitis, Contact/immunology , Dinitrofluorobenzene/administration & dosage , Dinitrofluorobenzene/immunology , Dinitrofluorobenzene/toxicity , Dose-Response Relationship, Drug , Ear, External/drug effects , Ear, External/pathology , Edema/chemically induced , Edema/pathology , Enzyme Inhibitors/pharmacology , Eosinophilia/drug therapy , Eosinophilia/immunology , Eosinophils/immunology , Eosinophils/pathology , Hypersensitivity, Delayed , Injections, Intradermal , Lymphocyte Activation , Mice , Mice, Inbred C3H , Prednisolone/pharmacology , Protease Inhibitors/pharmacology , Protease Inhibitors/therapeutic use , Serine Endopeptidases/administration & dosage , Serine Endopeptidases/pharmacology
5.
Biochem Biophys Res Commun ; 290(5): 1478-82, 2002 Feb 08.
Article in English | MEDLINE | ID: mdl-11820788

ABSTRACT

Chymase inhibitor reduced the increase in the number of dermal mast cells in 2,4-dinitrofluorobenzene-induced dermatitis in a dose-dependent manner. Intradermal injection of human chymase to mouse ear significantly increased histamine content, the marker for mast cell number in the skin. These results suggest that chymase released by mast cells may participate in local mast cell accumulation in a positive feedback fashion. Immunohistochemical analysis revealed that the intradermal injection of chymase reduces expression of stem cell factor (SCF) on surface of the skin keratinocytes. In addition, incubation of human keratinocytes with chymase in vitro resulted in release of SCF into the culture medium. Since soluble SCF is thought to regulate mast cell number, the chymase-induced mast cell accumulation may occur via the ability of chymase to process membrane-bound SCF on the epidermal keratinocytes.


Subject(s)
Dermis/cytology , Dermis/enzymology , Mast Cells/cytology , Mast Cells/enzymology , Serine Endopeptidases/physiology , Animals , Cell Count , Cell Movement/drug effects , Cells, Cultured , Chymases , Dermatitis, Contact/enzymology , Dermatitis, Contact/pathology , Dermis/metabolism , Dinitrofluorobenzene/pharmacology , Humans , Injections, Intradermal , Keratinocytes/enzymology , Keratinocytes/metabolism , Mast Cells/drug effects , Mice , Mice, Inbred C3H , Recombinant Proteins/administration & dosage , Recombinant Proteins/pharmacology , Serine Endopeptidases/administration & dosage , Serine Proteinase Inhibitors/pharmacology , Solubility , Stem Cell Factor/biosynthesis , Up-Regulation/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...